SavedAdd your journal

Journals / Güncel Retina Dergisi / 2018 / Cilt: 2 - Sayı: 2

Subthreshold Laser and Subliminal (Micropulse) Laser in Diabetic Retinopathy and Diabetic Macular Edema

Diyabetik Retinopati ve Diyabetik Maküla Ödeminde Eşik Altı Lazer ve Subliminal (Mikropulse) Lazer

MEHMET ÇITIRIK
MEHMET YASİN TEKE
Pages
177–184
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This article mentions about subthreshold laser, and subliminal (micropulse) laser in diabetic retinopathy and diabetic macular edema

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diabetic macular edema (DME) is one of the main causes of a significant reduction in visual acuity in a working-age adults and is the most common cause of visual acuity loss from diabetic retinopathy.
📊
Key Findings & Data:Most of studies have shown that the ability of conventional laser to maintain or improve visual acuity is limited, possibly because of the development of retinal scars, which decrease the potential for improved visual acuity.
💡
Conclusion & Impact:This article mentions about subthreshold laser, and subliminal (micropulse) laser in diabetic retinopathy and diabetic macular edema
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Diabetic macular edema (DME) is one of the main causes of a significant reduction in visual acuity in a working-age adults and is the most common cause of visual acuity loss from diabetic retinopathy. Most of studies have shown that the ability of conventional laser to maintain or improve visual acuity is limited, possibly because of the development of retinal scars, which decrease the potential for improved visual acuity. Subthreshold laser and subliminal (micropulse) laser has the potential to reduce DME with better visual acuity results compared with conventional laser, as it does not cause collateral damage in the retina. These lasers cannot cause permanent damage to the retina. This article mentions about subthreshold laser, and subliminal (micropulse) laser in diabetic retinopathy and diabetic macular edema

Özet

Diyabetik maküla ödemi (DMÖ), çalışma yaşındaki erişkinlerde görme keskinliğinde azalmanın ana nedenlerinden biridir ve diyabetik retinopatide görme kaybının en sık görülen nedenidir. Birçok çalışma, konvansiyonel lazerin retinada skar oluşturup görme keskinliğini azaltabilme özelliği nedeniyle görme keskinliğini koruma veya iyileştirme kabiliyetinin sınırlı olduğunu göstermektedir. Eşik altı lazer ve subliminal (mikropulse) lazer, retinada kollateral hasara neden olmadığı için konvansiyonel lazere kıyasla daha iyi görme keskinliği ile DMÖ'yü azaltma potansiyeline sahiptir. Bu lazerler retinada kalıcı hasara neden olmazlar. Bu yazıda diyabetik retinopati ve DMÖ'de eşik altı lazer ve subliminal (mikropulse) lazerden bahsedilecektir

🔖

Cite This Article

ÇITIRIK, M., TEKE, M. Y. (2018). Subthreshold Laser and Subliminal (Micropulse) Laser in Diabetic Retinopathy and Diabetic Macular Edema. Güncel Retina Dergisi, Cilt: 2 - Sayı: 2, 177–184. https://ajindex.com/articles/224257

References (13)

  1. Loewenstein A. Laser Use and the Future of Retina Practice. Retina Today. 2015; July/August: 34-36
  2. Çıtırık M, Teke MY. Lazer Kullanımının Güncel Retina Pratiğindeki Yeri. http://www.retinaclub.com/ Son Güncellenme Tarihi 01/07/2017 3- Stanga P. Subthreshold Retinal Treatment with Yellow 577-nm PASCAL Laser. Retina Today. 2013; 2013 January/February: 77-80
  3. Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, et al. Diabetic Retinopathy Clinical Research Network, Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015; 372(13): 1193-203
  4. Kiss S, Liu Y, Brown J, Holekamp NM, Almony A, Campbell J, Kowalski JW. Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema. Clin Ophthalmol. 2014; 8: 1611-21
  5. Karaçorlu M. Diyabetik Makula Ödeminin Lazer Tedavisinde Yeni Yaklaşımlar. Turkiye Klinikleri J Ophthalmol-Special Topics 2013;6(1):105-12
  6. Muqit MM, Henson DB, Young LB, Patton N, Charles SJ, Turner GS, et al. Laser tissue interactions. Ophthalmology. 2010; 117(10): 2039,2039.e1
  7. Muqit MM, Denniss J, Nourrit V, Marcellino GR, Henson DB, Schiessl I, et al. Spatial and spectral imaging of retinal laser photocoagulation burns. Invest Ophthalmol Vis Sci. 2011; 52(2): 994-1002
  8. Muqit MM, Gray JC, Marcellino GR, Henson DB, Young LB, Patton N, et al. Barely visible 10-millisecond pascal laser photocoagulation for diabetic macular edema: observations of clinical effect and burn localization. Am J Ophthalmol. 2010; 149(6): 979-986.e2
  9. Muqit MM, Young LB, McKenzie R, John B, Marcellino GR, Henson DB, et al. Pilot randomised clinical trial of Pascal TargETEd Retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study. Br J Ophthalmol. 2013; 97(2): 220-7
  10. Ober MD, Hariprasad SM. Retinal lasers: past, present, and future. Retina Physician. 2009;6(1):36-39 12- Kanski JJ. Clinical Ophthalmology A Systematic Approach (6th ed.), Butterworth-Heinemann, Oxford, United Kingdom (2007), pp. 566–584
  11. Balles MW, Puliafito CA, D’Amico DJ, Jacobson JJ, Birngruber R. Semiconductor diode laser photocoagulation in retinal vascular disease. Ophthalmology. 1990; 97(11): 1553-61
  12. Sramek CK, Leung LS, Paulus YM, Palanker DV. Therapeutic window of retinal photocoagulation with green (532-nm) and yellow (577-nm) lasers. Ophthalmic Surg Lasers Imaging. 2012; 43(4): 341-7
  13. Kerimoğlu